Tesla could be a $10,000 stock in a decade, says longtime bull Ron Baron
Cathie Wood’s ARK ETF published its daily trades for Thursday, November 13, 2025, revealing a series of strategic adjustments in its portfolio. The most significant trade of the day was the sale of 87,051 shares of Advanced Micro Devices Inc (NASDAQ:AMD) through the ARKK ETF, amounting to a total value of $22,536,633. This move indicates a significant reduction in ARK’s position in AMD, a stock that has been a staple in many tech-focused portfolios.
In contrast, ARK demonstrated confidence in Circle Internet Group Inc (CRCL) by purchasing 188,941 shares across its ARKK, ARKW, and ARKF ETFs, totaling $16,305,608. This marks a continuation of ARK’s interest in Circle, following a substantial purchase the previous day.
Another noteworthy acquisition was in Bitmine Immersion Technologies Inc (BMNR), with ARK buying 242,347 shares for $9,832,017, signaling a growing interest in the cryptocurrency and blockchain space.
ARK also increased its stake in Beam Therapeutics Inc (NASDAQ:BEAM) by acquiring 140,193 shares valued at $3,066,020. This follows a pattern of consistent buying of BEAM shares over the past week, emphasizing ARK’s bullish outlook on the biotech sector.
On the selling front, ARK reduced its holdings in Pinterest Inc (NYSE:PINS) by selling 572,735 shares worth $15,647,120, and in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) by offloading 12,083 shares valued at $8,237,222. These sales could reflect profit-taking or a strategic reallocation of funds.
Additionally, ARK made smaller transactions, such as buying 261,439 shares of Recursion Pharmaceuticals Inc (RXRX) for $1,215,691 and selling 21,974 shares of Salesforce Inc (NYSE:CRM) for $5,406,043.
Overall, ARK’s trades today highlight a mix of strategic exits and expansions, with a particular focus on tech and biotech sectors. Investors will be keen to see how these moves align with broader market trends and ARK’s long-term investment strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.